Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study
These results suggest that, in patients with HCC progressed to first-line atezolizumab plus bevacizumab, lenvatinib second-line therapy is associated to an improved survival compared to sorafenib.
Authors
- Francesco Giuseppe Foschi (ORCID: https://orcid.org/0000-0002-8216-0918)
- Silvia Foti
- Silvia Camera (ORCID: https://orcid.org/0000-0001-8203-1684)
- Jaekyung Cheon (ORCID: https://orcid.org/0000-0001-8439-1739)
- Hideko Ohama (ORCID: https://orcid.org/0000-0002-1882-824X)
- Norio Itokawa (ORCID: https://orcid.org/0009-0002-2390-6692)
- Joji Tani (ORCID: https://orcid.org/0000-0001-8801-2505)
- Ho Yeong Lim (ORCID: https://orcid.org/0000-0001-9325-2300)
- José Presa (ORCID: https://orcid.org/0000-0003-0861-4296)
- Kazuhito Kawata (ORCID: https://orcid.org/0000-0002-4986-8578)
- Margherita Rimini (ORCID: https://orcid.org/0000-0002-4047-2585)
- Luigi Mascia
- Kazuya Kariyama (ORCID: https://orcid.org/0000-0003-3996-7502)
- Fabian Finkelmeier (ORCID: https://orcid.org/0000-0001-8559-9910)
- Naoya Sakamoto (ORCID: https://orcid.org/0000-0003-0061-059X)
- Goki Suda (ORCID: https://orcid.org/0000-0003-0098-9106)
- Hironori Ochi (ORCID: https://orcid.org/0000-0002-4112-1015)
- Giuseppe Cabibbo (ORCID: https://orcid.org/0000-0002-0946-3859)
- Hidenori Toyoda (ORCID: https://orcid.org/0000-0002-1652-6168)
- Francesca Bergamo (ORCID: https://orcid.org/0000-0002-8795-4653)
- Kazuhiro Nouso (ORCID: https://orcid.org/0000-0002-2018-0008)
- Takeshi Hatanaka (ORCID: https://orcid.org/0000-0003-3656-285X)
- Naoshi Nishida (ORCID: https://orcid.org/0000-0002-9111-5668)
- Christoph Steup (ORCID: https://orcid.org/0000-0001-6991-9910)
- Fabio Piscaglia (ORCID: https://orcid.org/0000-0001-8264-1845)
- Masatoshi Kudo (ORCID: https://orcid.org/0000-0002-4102-3474)
- Mara Persano (ORCID: https://orcid.org/0000-0003-3600-0232)
- Mario Scartozzi (ORCID: https://orcid.org/0000-0001-5977-5546)
- Yoichi Hiasa (ORCID: https://orcid.org/0000-0003-4117-339X)
- Caterina Vivaldi (ORCID: https://orcid.org/0000-0001-9307-2326)
- Shigeo Shimose (ORCID: https://orcid.org/0000-0003-2068-8386)
- Atsushi Hiraoka (ORCID: https://orcid.org/0000-0003-1989-0480)
- Stefano Cascinu (ORCID: https://orcid.org/0000-0003-2215-0731)
- Takashi Kumada (ORCID: https://orcid.org/0000-0003-2211-495X)
- Francesco Vitiello (ORCID: https://orcid.org/0000-0002-3568-0232)
- Tomomi Okubo (ORCID: https://orcid.org/0000-0003-1244-4736)
- Takuya Nagano (ORCID: https://orcid.org/0000-0003-1043-8033)
- Ei Itobayashi (ORCID: https://orcid.org/0000-0003-0475-2819)
- Vera Himmelsbach
- Takuya Sho (ORCID: https://orcid.org/0000-0001-7943-3842)
- Masaki Kaibori (ORCID: https://orcid.org/0000-0002-0577-3921)
- Mariangela Bruccoleri (ORCID: https://orcid.org/0000-0001-7400-4854)
- Gianluca Masi (ORCID: https://orcid.org/0000-0001-8329-8989)
- Masashi Hirooka (ORCID: https://orcid.org/0000-0001-5634-5313)
- Hiroko Iijima (ORCID: https://orcid.org/0000-0002-5841-8827)
- Chikara Ogawa (ORCID: https://orcid.org/0000-0002-4534-6692)
- Hisashi Kosaka (ORCID: https://orcid.org/0000-0002-2926-9973)
- Federico Rossari (ORCID: https://orcid.org/0000-0003-4493-6380)
- Kazuto Tajiri (ORCID: https://orcid.org/0000-0002-2373-8601)
- Takashi Nishimura (ORCID: https://orcid.org/0000-0002-5517-8303)
- Hong Jae Chon (ORCID: https://orcid.org/0000-0002-6979-5812)
- Caterina Soldà (ORCID: https://orcid.org/0000-0002-2914-6674)
- Toshifumi Tada (ORCID: https://orcid.org/0000-0002-0976-6761)
- Atsushi Naganuma (ORCID: https://orcid.org/0000-0003-0663-0102)
- Margarida Montes
- Akemi Tsutsui (ORCID: https://orcid.org/0000-0003-2978-2723)
- Toru Ishikawa (ORCID: https://orcid.org/0000-0002-5470-9694)
- Masanori Atsukawa (ORCID: https://orcid.org/0000-0003-3374-7111)
- Tomoko Aoki (ORCID: https://orcid.org/0000-0002-9950-4553)
- Fujimasa Tada (ORCID: https://orcid.org/0009-0007-3964-5876)
- Hideki Iwamoto (ORCID: https://orcid.org/0000-0001-5688-1335)
- Massimo Alberto Iavarone (ORCID: https://orcid.org/0000-0003-3493-6504)
- Asahiro Morishita (ORCID: https://orcid.org/0000-0002-0760-3045)
- Andrea Casadei‐Gardini (ORCID: https://orcid.org/0000-0001-6289-7202)
- Koichi Takaguchi (ORCID: https://orcid.org/0000-0003-0175-8721)
- Michitaka Imai (ORCID: https://orcid.org/0000-0001-6448-6036)
- Satoru Kakizaki (ORCID: https://orcid.org/0000-0003-0224-7093)
- Changhoon Yoo (ORCID: https://orcid.org/0000-0002-1451-8455)
- Elisabeth Amadeo
- Yohei Koizumi (ORCID: https://orcid.org/0000-0003-3850-4063)
- Takashi Niizeki
- Satoshi Yasuda (ORCID: https://orcid.org/0000-0002-2266-2414)
- Noritomo Shimada
- Shinichiro Nakamura
- Kunihiko Tsuji
Institutions
- Kurume University (JP)
- University of Pisa (IT)
- Goethe University Frankfurt (DE)
- Ulsan College (KR)
- Kansai Medical University (JP)
- Vita-Salute San Raffaele University (IT)
- University of Cagliari (IT)
- Kagawa University (JP)
- Hokkaido University (JP)
- Samsung Medical Center (KR)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Hamamatsu University School of Medicine (JP)
- University of Ulsan (KR)
- Ospedale Maggiore (IT)
- Takamatsu Red Cross Hospital (JP)
- Saiseikai Niigata Daini Hospital (JP)
- Istituto Oncologico Veneto (IT)
- National Hospital Organization Takasaki Medical Center (JP)
- Matsuyama Red Cross Hospital (JP)
- Okayama Prefecture (JP)
- Azienda USL di Bologna (IT)
- Ospedale per gli Infermi (IT)
- Ogaki Municipal Hospital (JP)
- University Hospital Frankfurt (DE)
- Gunma Saiseikai Maebashi Hospital (JP)
- Himeji Red Cross Hospital (JP)
- CHA University Bundang Medical Center (KR)
- Teine Keijinkai Hospital (JP)
- Direção Geral do Território (PT)
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Asahi General Hospital (JP)
- Toyama University Hospital (JP)
- Ehime Prefectural Central Hospital (JP)
- CHA University (KR)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Kagawa Prefectural Central Hospital (JP)
- Otemae Hospital (JP)
- Azienda Ospedaliera Universitaria Pisana (IT)
- Azienda Ospedaliera G. Brotzu (IT)
- Ehime University (JP)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
- Gifu Kyoritsu University (JP)
- Nippon Medical School (JP)
- Hyogo University (JP)
- Sungkyunkwan University (KR)
- University of Palermo (IT)
- Kindai University (JP)
Publication Details
- Journal
- Oncology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1159/000541018
- Citations
- 5
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.85